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BACKGROUND: Whole blood donors are at risk of
becoming iron deficient. To monitor iron stores, Sanquin
implemented a new deferral policy based on ferritin
levels, in addition to the traditional hemoglobin
measurements.
METHODS: Ferritin levels are determined in every fifth
donation, as well as in all first-time donors. Donors with
ferritin levels <15 ng/mL (WHO threshold) are deferred
for 12 months; those ≥15 and ≤30 ng/mL for 6 months.
The first results were analyzed and are presented here.
RESULTS: The results show that 25% of women
(N = 20151, 95% CI 24%-25%) and 1.6% of men
(N = 10391, 95% CI 1.4%-1.8%) have ferritin levels
≤30 ng/mL at their first blood center visit. For repeat
(non-first-time) donors, these proportions are higher:
53% of women (N = 28329, 95% CI 52%-54%) and 42%
of men (N = 31089, 95% CI 41%-43%). After a 6-month
deferral, in 88% of returning women (N = 3059, 95% CI
87%-89%) and 99% of returning men (N = 3736, 95% CI
98%-99%) ferritin levels were ≥15 ng/mL. After a
12-month deferral, in 74% of returning women (N = 486,
95% CI 70%-78%) and 95% of returning men (N = 479,
95% CI 94%-97%) ferritin levels increased to ≥15 ng/mL.
CONCLUSION: Deferral of donors whose pre-donation
ferritin levels were ≤30 ng/mL might prevent donors from
returning with ferritin levels <15 ng/mL. This policy is
promising to mitigate effects of repeated donations on
iron stores.
S
anquin is the national blood service in The Nether-
lands. In addition to securing safe blood products
for patients, it has a responsibility to its voluntary
non-remunerated donors to diminish the risk of
developing health problems related to whole blood dona-
tion. One of these risks is iron deficiency anemia or iron
deficient erythropoiesis. During whole-blood donation, a
donor gives half a liter of blood, containing 210 to 240 mg
iron bound to hemoglobin (Hb).1 This iron is first replaced
from iron stores (of which ferritin level is an indicator),
which are then slowly replenished by an increased iron
uptake from food. These stores are on average 411 mg in
women under 50, 591 mg in women over 50, and 880 mg in
men.1-3 Thus, the amount of iron lost during donation is
relatively large in comparison to the total iron stores, espe-
cially in premenopausal women.
To monitor donorsʼ iron statuses, donorsʼ hemoglobin
levels are measured before each donation using a photome-
ter (HemoCue) after finger prick sampling. Donors are eligi-
ble for donation if their hemoglobin level is at least
7.8 mmol/L (12.6 g/dL) for women, or 8.4 mmol/L (13.5 g/
dL) for men. A hemoglobin level below this threshold may
indicate iron deficiency anemia, which needs to be
prevented. Yet, donors with normal hemoglobin levels can
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already be iron deficient without anemia.4 This happens
when the body is not given enough time to replenish its
iron stores between donations, using only hemoglobin mea-
surements as an iron marker.
Several studies have analyzed iron recovery after dona-
tion with similar results.5,6 In a study of 50 male donors,
followed after whole blood donation, blood volume is
restored first. About 4 days post-donation, hemoglobin
levels are at the lowest point and start to increase as stored
iron is released to replenish hemoglobin. At the same time,
ferritin levels decline and reach their lowest point about
29 days post-donation. After 56 days (the minimum interval
between two whole blood donations for men in The Nether-
lands), average measured ferritin levels are 27 ng/mL in
repeat male donors, compared to an average of 49 ng/mL
directly prior to donation. At that time point, the average
hemoglobin level is 9.1 mmol/L, almost back to the average
starting value of 9.2 mmol/L.5 Donors in this study did not
take iron supplements.
Several strategies to better monitor iron status in donors
have been proposed, such as hemoglobin-guided donation
intervals, ferritin-guided donation intervals, and iron supple-
mentation.7 Sanquin has chosen to implement a ferritin-
based deferral policy for its donors. The policy started in
November 2017; donors are deferred for 6 or 12 months in
case their ferritin levels are ≤30 or <15 ng/mL respectively,
even though their hemoglobin was above the threshold and
they were eligible to donate otherwise. These thresholds were
based on WHO standards, which state that ferritin levels
<15 ng/mL indicate iron deficiency, while higher levels reflect
the size of the iron stores.8 However, one should be aware
that ferritin is also an acute-phase reactant.9
The main aim of the policy is to prevent donorsʼ ferri-
tin levels from dropping below 15 ng/mL. Without regular
ferritin testing, donors with low ferritin levels (≤30 ng/mL)
but hemoglobin levels above the threshold will keep donat-
ing every few months, with the risk that their iron reserves
decline until hemoglobin levels fall below the threshold. By
measuring ferritin levels every fifth donation, Sanquin tries
to prevent donors from future deferral, thus preventing
them from becoming overt iron deficient (with or without
anemia). The choice to measure ferritin every fifth donation
rather than at a different frequency is arbitrary and not
based on extensive research.
Data on hemoglobin and ferritin levels collected during
the first 18 months since the implementation of this ferritin
deferral protocol were analyzed to determine: 1) the distri-
bution of ferritin levels in new donors, providing a reference
distribution of ferritin levels in healthy individuals that have
never donated blood before; 2) the difference in ferritin dis-
tribution between new and repeat donors; and 3) the differ-
ence in donor ferritin levels before and after deferral, which
provides information on the effectiveness of donor deferral
to prevent donors from returning to donate with iron
deficiency.
In evaluating the deferral policy based on ferritin levels,
there are three important aspects to consider. The first is the
effectiveness of the policy in preventing donors returning with
ferritin levels below 15 ng/mL. The second and third are the
effects of the policy on the blood supply and on donor health,
respectively. This article analyses the first aspect in depth; an
exhaustive analysis of all three aspects is outside the scope of
the current study and will become possible in due time.
METHODS
At Sanquin, the national blood establishment in The Neth-
erlands, every person who signs up to become a blood
donor is first invited for a donor intake. This initial visit is
meant to screen for infectious diseases and assessment of
blood type and potential antibodies, without donation. Pros-
pect donors that meet all the criteria of the donor health
questionnaire and have a negative infectious disease and
antibody screen become a blood donor and are invited for
their first donation a few weeks later.
The ferritin-based deferral policy prescribes that ferritin
is measured at the intake visit for all first-time donors, and
at every fifth donation in repeat donors. Donors are consid-
ered “first-time” donors only for their first donation and are
considered “repeat” donors after that. Unlike hemoglobin,
which is measured by point-of-care testing and gives the
result directly, ferritin is measured in serum samples which
are analyzed within a few days after the donation has taken
place. At the intake, this makes no difference, because no
donation takes place during this visit. However, for repeat
donors, the ferritin level is assessed after the donation has
taken place, from a sample pouch that is collected along
with the donated blood. This means that donors are
deferred after donation (they are notified of their deferral by
letter), and that ferritin measurements are available from
repeat donors that have hemoglobin levels above the dona-
tion threshold only. There is currently no evidence that
donating with low ferritin levels is dangerous or unhealthy,
as long as hemoglobin levels are adequate. Therefore, this
donation is considered to be safe even if the ferritin mea-
surement comes back below the threshold.
Ferritin levels are assessed with the Architect i2000 by
Abbott Diagnostics. Ferritin levels are divided into three cat-
egories with different consequences for the donor:
– Ferritin <15 ng/mL: the donor is deferred from donation
for 12 months.
– 15 ≤ Ferritin ≤30 ng/mL: the donor is deferred from dona-
tion for 6 months.
– Ferritin >30 ng/mL: no deferral, the donor can return for
the next donation after the regular minimum donation
interval (56 days for men, 122 days for women).
Sanquin does not have a policy to advise donors to take
iron supplements for low ferritin or hemoglobin levels,
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although they are free to take over-the-counter iron supple-
ments on their own initiative. The deferral periods are
meant to give the donors a “break” from blood donation,
allowing iron stores to recover solely by iron intake from
donorsʼ regular diets.
Sanquin collects approximately 400,000 whole blood
donations annually, from over 270,000 donors.10 Data for
this study were collected between November 2017 and April
2019 on donors who gave consent for the use of their data
for scientific research (>99% of all donors give this consent).
To compare the ferritin distributions in first-time and
repeat donors, for each donor only the first ferritin measure-
ment is considered. For first-time donors, this is the ferritin
measurement taken at the pre-donation screening. For repeat
donors, this is the ferritin measurement taken at the fifth
donation since the implementation of the protocol. If the
same donor has a consecutive ferritin measurement, five
donations later, that measurement is not used in this analy-
sis, so that every donor only occurs once in the data set.
To assess the effectiveness of the deferral for preventing
donors from returning to donate while iron deficient, we
compare pre-deferral ferritin levels to post-deferral ferritin
levels, of all deferred donors of whom post-deferral ferritin
measurements were available. We compared pre-deferral fer-
ritin levels in donors with and without a post-deferral mea-
surement to check for selection bias. In donors without post-
deferral measurement, we selected only those who were eligi-
ble for donation again (i.e., their deferral period has ended).
For donors who do have a post-deferral ferritin mea-
surement, we calculated the average daily increase in ferri-
tin levels for each donor. Note that since ferritin recovery
does not progress linearly, the averages do not represent
the actual increase on any given day,6 but this method can
be used to compare recovery rates between women
and men.
All analyses are performed in the R programming lan-
guage and environment for statistical computing.11 Plots are
produced with the ggplot2 package.12 Distributions are
asymmetric and are therefore characterized by the median
value and the interquartile range (IQR). Density plots pres-
ented are kernel density estimates; the bandwidth is
selected by Silvermanʼs rule of thumb.13
RESULTS
Ferritin levels were measured at least once in 30,542 first-
time donors (20,151 women) and 59,418 repeat donors
(28,329 women). Figure 1 shows the distribution of ferritin
levels for various combinations of sex and age categories. In
first-time donors, men had substantially higher ferritin
levels than women, and ferritin levels increased with age:
median ferritin levels ranged from 96 to 173 ng/mL in men
and from 43 to 81 ng/mL in women by age group. In repeat
donors, the median values were more similar for both sexes,
ranging from 22-35 ng/mL in men and from 28 to 36 ng/mL
in women. Table 1 shows the median ferritin level and IQR
for all age groups.
Overall, 25% of female first-time donors (95% CI 24%-
25%) and 1.6% of male first-time donors (95% CI 1.4%-1.8%)
had ferritin levels below the threshold of 30 ng/mL at the
intake visit. These proportions were considerably higher in
repeat donors: 53% of women (95% CI 52%-54%) and 42%
of men (95% CI 41%-43%) had a ferritin level ≤30 ng/mL.
These outcomes again show that men have significantly
higher ferritin levels than women (as witnessed by the con-
fidence intervals), and that repeat donors are much more
likely to have low ferritin levels than first-time donors,
although this difference is much more pronounced in men
(25-fold increase) than in women (two-fold increase). This
leads to substantially smaller differences in ferritin levels
between men and women for repeat donors than in first-
time donors.
Most donors with low ferritin levels had a ferritin level
between 15 and 30 ng/mL, but 5.3% of female first-time
donors and 0.1% of male first-time donors already had ferri-
tin levels <15 ng/mL. In repeat donors, these low levels
were observed in 15% of female and 9.4% of male donors.
We calculated the moving average (window size of
1000 observations) of the proportion of donors that were
deferred due to low ferritin levels as a function of age. We
did this separately for sex, donor type (new/repeat donor),
and ferritin deferral category (<15 ng/mL and between
15-30 ng/mL). In Fig. 2, the proportion of deferrals as a
function of donor age is shown for each combination of
deferral type, donor type, and sex. Confidence intervals are
not shown due to the proximity of the lines, but they are all
extremely narrow. The difference in deferral probability
between female and male donors was substantially larger in
new donors than in repeat donors. In male repeat donors,
the association between age and deferral rate was negative
and almost linear. In female repeat donors, there was a
clear non-linear dependency on age: after an initial
decrease until the age of 25, there was an increase until the
age of 40, after which it started to decrease again.
We also analyzed the difference between pre- and post-
deferral ferritin levels for both 6- and 12-month deferral. To
check for selection bias, we compared the pre-deferral ferri-
tin levels of donors with and without a post-deferral mea-
surement. Table 2 shows the number of deferred donors,
the number of donors whose deferral period has ended,
and those who have already returned. It shows that pre-
deferral ferritin levels in donors who returned after deferral
do not differ from those in the complete group. This indi-
cates that the group of donors with a post-deferral ferritin
measurement are likely to be a representative sample of all
deferred donors with respect to ferritin. However, there is a
difference in return rate between the sexes: approximately
80% of men versus only 60% of women have returned out of
those whose deferral period has ended. The return rates
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Fig. 1. Distributions of ferritin levels in new (solid line) and repeat donors (dashed line) for various combinations of sex and age
category. Sample sizes range from 1037 (male new donors age 50+) to 14,848 (male repeat donors age 50+).
TABLE 1. Median ferritin levels and interquartile range (IQR) in first-time and repeat donors, by sex and age category
Sex Age category
First-time donors Repeat donors
N Median ferritin level (IQR) N Median ferritin level (IQR)
Female 18-24 9713 43 (27-65) 4537 22 (15-33)
Female 25-34 5071 52 (33-79) 5045 26 (17-39)
Female 35-49 3801 58 (33-98) 7411 28 (18-43)
Female 50+ 1566 81 (50-128) 11,336 35 (23-53)
Male 18-24 3896 96 (66-135) 2048 28 (18-43)
Male 25-34 3424 136 (95-191) 3928 34 (21-53)
Male 35-49 2167 154 (102-224) 7063 35 (22-56)
Male 50+ 904 173 (120-256) 18,050 36 (23-56)
Fig. 2. Probability of deferral due to low ferritin as a function of age in repeat (black) and new (gray) donors. Both deferral for 6 months
(ferritin between 15 and 30 ng/mL, dashed line) and deferral for 12 months (ferritin under 15, solid line) are shown. The difference in age
ranges is due to the fact that new donors are only accepted until the age of 65, whereas repeat donors can keep donating for several more years.
1788 TRANSFUSION Volume 60, August 2020
VINKENOOG ET AL.
include donors who have returned after deferral but did not
have a repeat ferritin measurement due to a low hemoglo-
bin level.
After a ferritin deferral period, the deferral rate due to low
hemoglobin levels is considerably lower than it is in general. The
overall hemoglobin deferral rate is 8.4% for women and 4.6% for
men. After a 12-month deferral, 6.1% of women and 1.6% of men
are immediately deferred again because their hemoglobin levels
are below the threshold. After a six-month deferral, these per-
centages are 4.4% for women and 2.8% for men.
The changes in ferritin levels after 6- and 12-month
deferrals are summarized in Table 3. After either deferral
period, the majority of donors who returned had an
increased ferritin level, men more so than women. More
than 95% of returning male donors had a ferritin level of
15 ng/mL or higher after either deferral type. In female
donors, this proportion was 88% after six-month deferral
and 73% after 12-month deferral. The difference in ferritin
recovery rate between men and women makes sense con-
sidering the differences in ferritin levels observed in first-
time donors. These differences can likely be attributed to
the same physiological cause(s).
The rate of ferritin recovery differed between female
and male donors. The median of the average daily increase
in women was higher for 12-month deferral than for six-
month deferral: 0.030 ng/mL/day versus 0.016 ng/mL/day.
In men, they were more similar: 0.068 ng/mL/day for
12-month deferral and 0.071 ng/mL/day for six-month
deferral. After either period of deferral, ferritin recovery
rates were substantially higher in men than in women.
DISCUSSION
This study shows that in first-time donors who have never
donated blood, womenʼs ferritin levels are lower than
menʼs, and they increase with age. Ferritin levels in repeat
donors are substantially lower and therefore the deferral
rate is higher, for both sexes. The difference in ferritin levels
between male and female donors is considerably smaller in
repeat than in first-time donors, regardless of age. Finally,
after having a measured ferritin level below 30 ng/mL and
being deferred for 6 or 12 months, the vast majority of
returning female and almost all returning male donors have
ferritin levels of 15 ng/mL or higher.
The differences we have observed between male and
female first-time donors can partly be explained by the
effect of the menstrual cycle on iron stores. After meno-
pause, this additional iron loss is no longer present and
womenʼs ferritin levels increase.14 The fact that sex differ-
ences are much smaller among repeat donors suggests that
regular blood donation leads to a lower ferritin level, which
TABLE 2. The total number of donors deferred, those that are eligible to return for donation at the time of analysis for
this study (deferred at least 7 months ago for 6-month deferral, and at least 13 months ago for 12-month deferral), and
those that have already returned for donation. For each group the median ferritin level and interquartile range (IQR) at
deferral are given. Percentages behind the number of donors returned after deferral are with respect to the number of
donors whose deferral period has ended and therefore could have returned after deferral
Six-month deferral Twelve-month deferral
Female Male Female Male
Number of donors deferred 15,008 10,296 5974 2952
Median ferritin at deferral (IQR) 22 ng/mL (19-26) 22 ng/mL (18-26) 11 ng/mL (9-13) 12 ng/mL (10-13)
Number of donors whose deferral period has ended 6181 4576 906 596
Median ferritin at deferral (IQR) 23 ng/mL (19-26) 22 ng/mL (18-26) 10 ng/mL (8-12) 12 ng/mL (10-13)
Number of donors returned after deferral 3258 (53%) 3883 (85%) 540 (60%) 490 (82%)
Median ferritin at deferral (IQR) 22 ng/mL (18-26) 22 ng/mL (18-26) 11 ng/mL (9-13) 12 ng/mL (10-13)
TABLE 3. Ferritin levels of donors who return after 6-month deferral (ferritin level between 15 and 30 ng/mL) or
12-month deferral (ferritin level <15 ng/mL). Symbols in the bottom three rows indicate whether the ferritin level has
dropped (#), has gone up one (") or two ("") categories, or has stayed in the same category (=)
Six-month deferral Twelve-month deferral
Female Male Female Male
Number of donors returned 3059 3736 486 479
Donors with increased ferritin 61% 91% 91% 99%
Median total increase (IQR) 4 ng/mL (−3-11) 15 ng/mL (7-25) 12 ng/mL (5-22) 27 ng/mL (16-39)
Median increase per day 0.016 ng/mL 0.071 ng/mL 0.030 ng/mL 0.068 ng/mL
Ferritin after deferral <15 ng/mL 12% (#) 1.5% (#) 26% (=) 4.6% (=)
Ferritin after deferral 15-30 ng/mL 54% (=) 30% (=) 43% (") 27% (")
Ferritin after deferral >30 ng/mL 34% (") 68% (") 30% ("") 68% ("")
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impacts men more than women as their natural ferritin
stores are generally higher. Multiple studies have found that
an increase in the number of donations results in decreased
iron stores, even though hemoglobin levels remain above
the threshold for donation.15,16 Our results suggest that this
relationship is less strong in women. This can be explained
by the shorter minimum donation interval for men (56 days
vs. 122 days for women), which allows them to donate five
times a year, compared to three times a year for women.
Also, donation frequency is the best predictor for decreased
iron stores.17 Further research into the precise relationship
between donation frequency, total number of donations and
trends in ferritin levels is ongoing, for instance in the
INTERVAL study.16 Another explanation is that women are
more easily deferred than men; the hemoglobin threshold
for donation is much closer to the average hemoglobin
value in women than in men. Women with low iron stores
are already deferred by the hemoglobin test alone, so their
(likely low) ferritin levels have not been measured in this
study.
Sex differences can also be seen in the percentage of
donors that return after donation: men are more likely to
return than women. Before we try to explain this difference,
we should keep in mind that donors only come back after
they are actively invited by Sanquin by means of an invita-
tion algorithm (based on daily demand for blood and blood
types). The effect of this procedure may hinder the outcome
of the current analysis. However, studies on donor return
rates after deferral are consistent in finding a higher return
rate for men than for women, although the magnitude of
the difference varies.18-20
Regarding the increase in ferritin after deferral, we
assume that this is larger than what would have occurred in
case the donors had not been deferred according to the pol-
icy. This assumption is based on studies mentioned in the
introduction, which show that donors need at least 168 days
for ferritin levels to recover.5,6 This indicates that a longer
deferral period gives donors more time to restore their ferri-
tin stores by taking a break from their regular donation
schedule. Nonetheless, a considerable number of donors is
deferred again based on their ferritin level upon their
return, especially women.
In male donors, the average daily ferritin increase is
higher in donors who were deferred for 6 months than in
those deferred for 12 months. This is interesting, because
during the first 29 days after donation, ferritin levels are still
decreasing.6 It might indicate that after the initial decrease,
ferritin recovery starts off at a high rate which then tapers
off. We see different results in women: the average daily fer-
ritin increase is higher in women deferred for 12 months
than those deferred for 6 months. Even though recovery
rates of donors deferred for 12 versus 6 months cannot be
compared because of their different ferritin levels before
deferral (<15 vs. ≤30 ng/mL), it is remarkable that the ratio
between these rates differs between men and women. One
explanation might be that ferritin recovery takes longer for
women, so the increase starts later in the process. However,
no differences between men and women were found in fer-
ritin recovery speed in control groups of oral iron supple-
mentation studies, although sample sizes were relatively
low (about 20 people per group).5,21 A larger-scale study
that measures donorsʼ ferritin levels in the weeks following
a donation could provide more insight.
Some blood services supply blood donors with iron
supplements in order to prevent iron deficiency, which can
lead to restless-leg syndrome and pica, especially
pagophagia, the inclination to chew ice.22,23 There is no
solid evidence for an association between low iron stores
and fatigue and cognition.23 Some studies did find that iron
supplements improve cognition in adolescents and women,
but most of these have small sample sizes and are method-
ologically weak, with evidence of publication bias.21 The
INTERVAL study did not find any effect of shortening the
donation interval on cognitive function in an analysis of
health survey questionnaires given to more than 45,000
donors.16 An analysis on more than 16,000 donors partici-
pating in the Danish Blood Donor Study did not find an
association between low ferritin levels and self-reported
mental and physical health either.24
Regardless of its possible health effects, several studies
have shown that iron supplementation increases the speed
of recovery of iron stores and hemoglobin levels after blood
donation.5,25 However, iron supplementation can also have
unintended and unwanted side effects, which may impact
compliance of iron supplementation and can deter donors.
For this reason, as well as the lack of scientific consensus
on how iron supplementation in blood donors should be
installed, Sanquin chose to introduce ferritin-guided dona-
tion intervals rather than iron supplementation to mitigate
effects of repeated donation on iron stores.
Although the ferritin-guided deferral policy seems to
help donors maintain appropriate ferritin levels, it also
raises some concerns. In the past few years, the proportion
of new female donors under 25 years of age has been
increasing rapidly in The Netherlands.26 Ferritin levels
below 30 ng/mL are very common among young women
who have never donated blood. If this trend continues, the
proportion of first-time donors that immediately gets
deferred from donation based on ferritin levels will continue
to increase. Deferral of these potential donors may lead to a
lower availability of blood products and has a larger effect
on the blood supply than hemoglobin-based deferral. One
to three donations are lost for every 6-month deferral, and
three to five for every 12-month deferral, depending on sex.
Additionally, by deferring donors not only for low hemoglo-
bin, but also for low ferritin levels, the chances of a donor
being deferred are increased. However, for the long-term
this increased chance may decrease again, as deferral due
to low ferritin can lower hemoglobin deferral rates. In our
data set, we found that the hemoglobin deferral rate
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decreases by half after ferritin deferral as compared to the
overall hemoglobin deferral rate. Deferral can also cause
donors to become unmotivated and not return to the blood
center, especially first-time donors.18,19 Compensating for
lost donations by recruiting new donors could therefore be
a less desirable consequence. Therefore, it is important to
carefully monitor donor availability when introducing ferritin-
guided donation intervals. One should also note that the fre-
quency of measuring ferritin levels (every fifth donation) is
mostly arbitrary and loosely based on a trade-off between
cost and benefit. Measuring more often would identify
donors at risk of iron deficiency earlier, but also increases
cost and loss of potential donations due to deferral.
From our results, we conclude that repeat donors have
considerably lower ferritin levels and smaller differences
between sexes in comparison to first-time donors. Deferral
of donors with ferritin levels ≤30 ng/mL seems to prevent
the majority of donors, male donors in particular, from
returning to donate with iron deficiency.
Comparisons to a control group are needed to establish
whether ferritin levels are indeed higher in groups of donors
than they would have been without ferritin-guided donation
intervals. Furthermore, longer-term research is needed to
assess whether this policy can maintain donorsʼ ferritin
levels within the appropriate range.
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